Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 20/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18281158 | 0.93 | RORC (0.55) | RORCKCNH2CYP2D6 | |
| SCHEMBL18275198 | 0.81 | RORC (0.56) | RORCKCNH2CYP2D6 | |
| SCHEMBL16799959 | 0.78 | RORC (0.76) | RORCKCNH2CYP2D6 | |
| SCHEMBL20239345 | 0.77 | RORC (0.59) | RORC | |
| SCHEMBL20239353 | 0.77 | RORC (0.59) | RORC | |
| SCHEMBL20239346 | 0.77 | RORC (0.59) | RORC | |
| SCHEMBL18281161 | 0.76 | RORC (0.58) | RORCKCNH2CYP2D6 | |
| SCHEMBL18275208 | 0.76 | RORC (0.60) | RORCKCNH2CYP2D6 | |
| SCHEMBL20180720 | 0.76 | RORC (0.48) | RORCKCNH2CYP2D6 | |
| SCHEMBL16799539 | 0.76 | RORC (0.63) | RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190040012-A1 | ROR GAMMA (RORY) MODULATORS | LEAD PHARMA HOLDING B.V. (NL) | 2019-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040012-A1 | ROR GAMMA (RORY) MODULATORS | RORC, RORA, RORB | RORC 1/4885KCNH2 2115/4885CYP2D6 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.